SCHEMBL3950463

SCHEMBL3950463

NC(=O)c1csc(-c2ccc3[nH]ccc3c2)n1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.60
CHEK1 O14757 2/20 0.53
GUSB P08236 6/20 0.48
PI4K2A Q9BTU6 1/20 0.46
HTR2B P41595 1/20 0.46
AR P10275 1/20 0.45
ACHE P22303 1/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP2C9 P11712 1/20 0.44
SCN9A Q15858 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
PTGS2 P35354 1/20 0.42
CYP2C19 P33261 1/20 0.42
PSMB8 P28062 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714645 0.80 EGFR (0.60) EGFRCHEK1GUSBALDH1A1CYP2C19
SCHEMBL29986893 0.76 EGFR (1.00) EGFRALDH1A1
SCHEMBL725160 0.76 EGFR (1.00) EGFRALDH1A1
SCHEMBL13680616 0.76 EGFR (0.51) EGFRCHEK1GUSBCYP2C9CA12
SCHEMBL17136835 0.75 SCN9A (0.51) PI4K2AARSCN9ACA12CA1
SCHEMBL3538991 0.74 CHEK1 (0.51) EGFRCHEK1GUSBALDH1A1
SCHEMBL5326402 0.73 MAPT (0.62) CHEK1ALDH1A1
SCHEMBL1785268 0.73 HTR2B (0.59) HTR2BACHEALDH1A1CYP2C19
SCHEMBL1249544 0.72 RAB9A (0.66) HTR2BACHEALDH1A1CYP2C19
SCHEMBL999473 0.72 HDAC1 (0.69) HTR2BACHEALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010508-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES AstraZeneca AB (SE) 2009-01-07 EP disclosed
WO-2007120096-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-10-25 WO disclosed